Faroogh Marofi

4.9k total citations · 1 hit paper
62 papers, 2.7k citations indexed

About

Faroogh Marofi is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Faroogh Marofi has authored 62 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 19 papers in Oncology and 17 papers in Immunology. Recurrent topics in Faroogh Marofi's work include CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (8 papers) and Virus-based gene therapy research (7 papers). Faroogh Marofi is often cited by papers focused on CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (8 papers) and Virus-based gene therapy research (7 papers). Faroogh Marofi collaborates with scholars based in Iran, Russia and Iraq. Faroogh Marofi's co-authors include Zohreh Babaloo, Tohid Gharibi, Arezoo Hosseini, Behzad Baradaran, Navid Shomali, Mehdi Yousefi, Mostafa Jarahian, Max Stanley Chartrand, Heshu Sulaiman Rahman and Ali Hassanzadeh and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Gene.

In The Last Decade

Faroogh Marofi

61 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CAR T cells in solid tumors: challenges and opportunities

2021 395 citations Faroogh Marofi, Roza Motavalli et al. Stem Cell Research & Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Faroogh Marofi Iran	30	1.1k	996	867	348	292	62	2.7k
Navid Shomali Iran	28	1.0k 1.0×	1.1k 1.1×	726 0.8×	611 1.8×	267 0.9×	78	2.6k
Shuang Qin China	23	2.1k 2.0×	1.3k 1.3×	1.4k 1.6×	489 1.4×	288 1.0×	78	3.9k
Sònia Tugues Switzerland	25	1.1k 1.0×	1.2k 1.3×	1.5k 1.7×	334 1.0×	216 0.7×	40	3.6k
Tsz‐Kwong Man United States	28	702 0.7×	1.4k 1.4×	361 0.4×	417 1.2×	196 0.7×	73	2.9k
Jack D. Bui United States	33	1.5k 1.4×	1.3k 1.4×	2.5k 2.9×	353 1.0×	310 1.1×	81	4.2k
Lukas J.A.C. Hawinkels Netherlands	31	2.1k 2.0×	1.9k 1.9×	1.6k 1.9×	895 2.6×	324 1.1×	99	4.8k
Anca Maria Cîmpean Romania	24	1.0k 1.0×	1.2k 1.2×	388 0.4×	563 1.6×	184 0.6×	180	2.9k
Judith H. Harmey Ireland	24	755 0.7×	1.3k 1.3×	464 0.5×	641 1.8×	257 0.9×	35	2.7k
Junnian Zheng China	30	1.1k 1.1×	1.7k 1.7×	492 0.6×	561 1.6×	235 0.8×	146	3.0k
Peng Xu China	22	760 0.7×	899 0.9×	392 0.5×	178 0.5×	281 1.0×	117	2.0k

Countries citing papers authored by Faroogh Marofi

Since Specialization

Citations

This map shows the geographic impact of Faroogh Marofi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faroogh Marofi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faroogh Marofi more than expected).

Fields of papers citing papers by Faroogh Marofi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faroogh Marofi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faroogh Marofi. The network helps show where Faroogh Marofi may publish in the future.

Co-authorship network of co-authors of Faroogh Marofi

This figure shows the co-authorship network connecting the top 25 collaborators of Faroogh Marofi. A scholar is included among the top collaborators of Faroogh Marofi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faroogh Marofi. Faroogh Marofi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Farsani, Mehdi Allahbakhshian, et al.. (2023). An overview of the molecular and clinical significance of the angiopoietin system in leukemia. Journal of Receptors and Signal Transduction. 43(2). 50–61. 2 indexed citations

Al‐Haideri, Maysoon, et al.. (2023). CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies. Medical Oncology. 40(5). 155–155. 7 indexed citations

Gharibi, Tohid, Arezoo Hosseini, Faroogh Marofi, et al.. (2023). STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance. International Immunopharmacology. 119. 110160–110160. 7 indexed citations

Mohammed, Rebar N., Heshu Sulaiman Rahman, Ali Adili, et al.. (2022). Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19). Cell Communication and Signaling. 20(1). 90–90. 1 indexed citations

Sorkhabi, Amin Daei, Aila Sarkesh, Hossein Saeedi, et al.. (2022). The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme. Frontiers in Oncology. 12. 818447–818447. 14 indexed citations

Marofi, Faroogh, Safa Tahmasebi, Heshu Sulaiman Rahman, et al.. (2021). Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism. Stem Cell Research & Therapy. 12(1). 217–217. 18 indexed citations

Mohammadi, Fatemeh, Fatemeh Ezzatifar, Armita Mahdavi Gorabi, et al.. (2021). Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019. International Immunopharmacology. 100. 108076–108076. 31 indexed citations

Razeghian, Ehsan, Mahyuddin K. M. Nasution, Heshu Sulaiman Rahman, et al.. (2021). A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies. Stem Cell Research & Therapy. 12(1). 428–428. 91 indexed citations

Marofi, Faroogh, Ria Margiana, Wanich Suksatan, et al.. (2021). MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy. Stem Cell Research & Therapy. 12(1). 597–597. 46 indexed citations

10.

Marofi, Faroogh, Safa Tahmasebi, Heshu Sulaiman Rahman, et al.. (2021). Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism. Stem Cell Research & Therapy. 12(1). 443–443. 4 indexed citations

11.

Rahman, Heshu Sulaiman, Marwah Suliman Maashi, Svetlana Danshina, et al.. (2021). MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers. Genes & Diseases. 9(4). 849–867. 25 indexed citations

12.

Marofi, Faroogh, Heshu Sulaiman Rahman, Lakshmi Thangavelu, et al.. (2021). Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy. Stem Cell Research & Therapy. 12(1). 200–200. 38 indexed citations

13.

Hosseini, Arezoo, Zohreh Babaloo, Tohid Gharibi, et al.. (2020). Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease. BMC Research Notes. 13(1). 568–568. 12 indexed citations

14.

Salimi, Leila, Pishva Arzhang, Faroogh Marofi, et al.. (2020). Interaction of opioid with insulin/IGFs signaling in Alzheimer's disease. Journal of Molecular Neuroscience. 70(6). 819–834. 5 indexed citations

15.

Gharibi, Tohid, Arezoo Hosseini, Faroogh Marofi, et al.. (2019). IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression. Immunology Letters. 216. 12–20. 29 indexed citations

16.

Eghbal‐Fard, Shadi, et al.. (2018). MicroRNAs and signaling networks involved in epithelial–mesenchymal transition. Journal of Cellular Physiology. 234(5). 5775–5785. 30 indexed citations

17.

Ghaebi, Mahnaz, Samaneh Abdolmohammadi‐Vahid, Majid Ahmadi, et al.. (2018). T cell Subsets in Peripheral Blood of Women with Recurrent Implantation Failure. Journal of Reproductive Immunology. 131. 21–29. 58 indexed citations

18.

Dianat‐Moghadam, Hassan, Mohsen Rokni, Faroogh Marofi, Yunes Panahi, & Mehdi Yousefi. (2018). Natural killer cell–based immunotherapy: From transplantation toward targeting cancer stem cells. Journal of Cellular Physiology. 234(1). 259–273. 49 indexed citations

19.

Dolati, Sanam, Faroogh Marofi, Zohreh Babaloo, et al.. (2018). Dysregulated Network of miRNAs Involved in the Pathogenesis of Multiple Sclerosis. Biomedicine & Pharmacotherapy. 104. 280–290. 55 indexed citations

20.

Dolati, Sanam, Majid Ahmadi, Faroogh Marofi, et al.. (2018). Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators. Pharmacological Reports. 70(6). 1158–1167. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact